| Aura pretty title | ||||
|---|---|---|---|---|
|
  |   |
| Aura pretty title | ||||
|---|---|---|---|---|
|
| Aura expand group | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||||||
Dr. Mathew’s main focus is the translation of research evidence to health-care practice in developing countries. He contributed significantly towards capacity building efforts for evidence-informed decision-making through the SIGNET programme (2009-14). He also developed the KNOW ESSENTIALS tool (2011) for evidence-informed decision-making in resource-limited settings. Dr. Mathew has recently developed a unique model of creating evidence-based clinical practice guidelines, without external funding; which can be emulated in diverse resource-constrained settings across the world. Dr. Mathew served as a member of the GIN Board of Trustees (2019-2023), and the Founder Chair of the GIN Low- and Middle-Income Countries (LMIC) Working Group (2015-2021). He is a founding member of the South Asian Cochrane Network Centre (currently designated as Cochrane India Network). He has served on the Board of Health Technology Assessment International (HTAi) and was the Founder Chair of the HTAi Developing Countries Interest Subgroup (2008-13). He has been a Chair/member of several committees of GIN, HTAi, Cochrane, World Health Organization, Evidence Synthesis Taxonomy Initiative (ESTI), COVID RecMap Project, Indian Council of Medical Research, and Society for Medical Decision Making (SMDM).
Dr Jeremy Grimshaw MBChB, PHD is an internationally recognised leading scholar in knowledge translation and implementation science. He is a Senior Scientist Emeritus, Clinical Epidemiology Program, Ottawa Hospital Research Institute, an Emeritus Professor in the Department of Medicine, University of Ottawa and held a Tier 1 Canada Research Chair in Health Knowledge Transfer and Uptake (2002-2022). He has made substantive contributions to global evidence synthesis activities for over 30 years including: Cochrane - Co-ordinating Editor of the Cochrane Effective Practice and Organisation of Care group (1997-2015), Director of Cochrane Canada (2005-2016), Co-Chair Cochrane Steering Group 2010-2014; Campbell Collaboration – Chair of the Board (2015-2024); Evidence Synthesis International - Co-Chair 2015 onwards; COVID Network for Evidence Informed Decisions COVIDEND - Co lead (2020-2022); and Global Commission on Evidence to address Societal Challenges - Co-lead (2022-2025). |
| Aura pretty title | ||||
|---|---|---|---|---|
|
21 October, 2024 breakout sessions - notes and slides
During this meeting participants were separated into breakout sessions to identify the purpose and 5 key priorities for the group. Meeting details, including the recording and slides can be found here.
Slides
| Aura divider | ||||
|---|---|---|---|---|
|
Group1
| Group 2
|
| Aura divider | ||||
|---|---|---|---|---|
|
| Aura pretty title | ||||
|---|---|---|---|---|
|
| Aura panel | ||||
|---|---|---|---|---|
| ||||
Christine Chang, Agency for Healthcare Research and Quality, Guidelines International Network, United States, Health Andrea Cook, Executive Director, UN SDG System-Wide Evaluation Office Emmanuel Effa, Cochrane Nigeria and University of Calabar, Nigeria, Nigeria, Health Ismael Kawooya, Center for Rapid Evidence Synthesis (ACRES) Uganda, My work is not sector specific Anne-Claire Luzot, Director of Evaluation, World Food Programme Enrique Mendizabal, OTT Consulting, Europe and Central Asia, Economic affairs (e.g. economic growth, employment), Education, International development Isabelle Mercier, Director of Evaluation, UNDP Alma Cristal Hernández Mondragón, INGSA/GYA/AMEXAC/Cinvestav, México, My work is not sector specific Shaheen Motala-Timol, INGSA-Africa, Mauritius, Education Bianca Pilla, Global Relations, JBI, Australia, Health. Rakesh Pilla, Epi Fractals Biosystems Pvt Ltd, India, Health Andrew Pullin, Collaboration for Environmental Evidence, UK, Climate (and environmental protection more generally) Arash Rashidian, Director Science, Information and Dissemination WHO (EMR), Egypt, Health Poya Saffari, Deputy Director of Corporate Planning, Performance and Risk Management, Global Affairs Canada Maureen Smith, Global Commission on Evidence to Address Societal Challenges, Canada, Health Birte Snilstveit, 3ie, Norway, Climate (and environmental protection more generally), Education, International development, Social protection (e.g. financial protection, children & social services) Ruth Stewart, The Alliance for Living Evidence,South Africa, My work is not sector specific Ligia Teixeira, Centre for Homelessness Impact, UK, Health, Housing and community amenities (e.g. transportation and other infrastructure), Social protection (e.g. financial protection, children & social services) Ngem Bede Yong, eBASE Africa Cameroon, Health Ex Officio Isabel Fletcher, Technology Manager, Wellcome trust |